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Chronic HCV infection induces insulin resistance (IR). We studied this in a persistently infected cell line
with defects in glucose homeostasis resulting from the phosphorylation of glycogen synthase (GS Ser641)
and GS kinase isoform 3b (GSK 3bSer9). Reversal of these effects in cells cured of HCV with interferon
supports viral speciﬁcity. Insulin signaling was disrupted by IRS-1 Ser312 phosphorylation and dysregula-
tion of the Akt pathway. In infected cells, active autophagy was revealed by the formation of LC3 puncta or
by increased levels (50–200%) of the markers Beclin 1 and conjugated Atg5/Atg12. Inhibition of autophagy
by 3-methyl-adenine (3-MA) reduced Beclin1 levels, inhibited IRS-1 Ser312 or GS Ser641 phosphorylation
and decreased viral load. Furthermore, IRS-1 Ser312 and Beclin1 were co-immunoprecipitated suggesting
that they interact. It thus appears that HCV infection disturbs glucose homeostasis or insulin signaling to
induce IR and also elicits autophagy that may contribute to this process.
& 2012 Elsevier Inc. All rights reserved.Introduction
More than 200 million people worldwide are infected with
hepatitis C virus (HCV). From 60–80% of these will become chroni-
cally infected and are at high risk for developing chronic hepatitis,
cirrhosis and hepatocellular carcinoma. In addition, recent epide-
miological studies indicate that the incidence of type 2 diabetes
mellitus (T2DM) is about 3 times higher in HCV-infected individuals
when compared to those who have spontaneously cleared their
infection, to those with chronic hepatitis B or to an uninfected
population (Mehta et al., 2000). In patients with chronic hepatitis C,
the virus is known to induce insulin resistance (IR), and IR is
associated with the development of T2DM, steatosis, progression
of ﬁbrosis and non-responsiveness to conventional interferon ther-
apy, but the molecular basis is not understood at present (D’Souza
et al., 2005; Romero-Gomez et al., 2005).
When bound to its receptor (IRc), insulin activates intrinsic
tyrosine (Tyr) kinase activity to induce Tyr phosphorylation of
insulin receptor substrates 1 and 2 (IRS-1 and IRS-2). These
phosphorylated substrates bind to the IRc and serve as the binding
sites for the p85 subunit of phosphatidylinositol 3-kinase (PI-3K)
downstream (Summers et al., 1999). Although the mechanism is
complex, Tyr phosphorylation of IRS-1 serves as a positive signal
(Zick, 2001). The impairment of postreceptor signaling generally
involves phosphorylation of serine/threonine (Ser/Thr) residues of
IRS-1 by potential IRS kinases including c-jun-N-terminal kinasell rights reserved.
e, One Baylor Plaza, BCM-385
90.(JNK), protein kinase C zeta (PKCx), mammalian target of rapamy-
cin (mTOR) and glycogen synthase kinase (GSK-3) (Aguirre et al.,
2002; Gopal et al., 2006; Kanazawa et al., 2004; Liberman and
Eldar-Finkelman, 2005). Ser residues in the phosphotyrosine bind-
ing (PTB) domain of IRS-1, such as Ser312, are of special interest as
they can inhibit the binding of Tyr phosphorylated IRS-1 to the IRc
or the PI-3K docking proteins downstream (Herschkovitz et al.,
2007; Liu et al., 2004). This inhibitory Ser phosphorylation is part of
a negative feedback to insulin signaling and serves as a mechanism
for cross talks from other pathways that are induced or are affected
by IR. Phosphorylation of Akt at either Thr308 or Ser473 down-
stream of the PI-3K/Akt pathway is critical for its activation and
subsequent inactivation of glycogen synthase (GS). This is
mediated through GS Ser641 phosphorylation by GSK-3 inhibiting
glycogen synthesis (Cross et al., 1995; Roach, 2002; Skurat and
Roach, 1995). Two different isoforms of GSK-3, GSK-3a and GSK-
3b, are active in a tissue-speciﬁc manner, b being more active in
the muscle and in resting cells, and a in the liver (Patel et al., 2008).
They are inactivated by Ser9 and Ser21 phosphorylation, respec-
tively (Sutherland et al., 1993). The speciﬁc roles of the two GSK-3
isoforms are not well understood, but they are not functionally
identical as initially described (Wang et al., 1994). More impor-
tantly, the status of GS and of individual GSK-3 isoforms in HCV
infection has not been elucidated yet.
In the past, GSK-3b has been the major focus of research in
cellular growth, proliferation and metabolism (Jope et al., 2007;
Patel et al., 2008). It reduced GS activity when over expressed in
transgenic animals or in transfected cells suggesting that the
active form of GSK-3b may be involved in inducing IR (Pearce
et al., 2004; Summers et al., 1999). More recently, gene knock out
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an early embryonic stage, whereas GSK-3a knockout mice are
viable and fertile, providing compelling evidence that GSK-3a
does not compensate for the loss of GSK-3b function (Hoeﬂich
et al., 2000). Also, inactivation of GSK-3a results in improved
insulin signaling and glucose homeostasis compared to tissue-
speciﬁc GSK-3b knock out mice thereby suggesting its important
role in T2DM (MacAulay et al., 2007; Patel et al., 2008). Unlike
GSK-3b which shuttles between the nucleus and the cytoplasm,
GSK-3a is excluded from the nucleus controlled by its N-terminal
region (Azoulay-Alfaguter et al., 2011). As mentioned earlier, GSK-
3 activation is mediated through phosphorylation of two Akt
residues, Thr308 by protein kinase PDK1, and Ser473 by the
mTORC2 complex involving Rictor (Alessi et al., 1997; Sarbassov
et al., 2005a). Both active forms of Akt are capable of phosphor-
ylating the inhibitory residues Ser21 and Ser9 on GSK-3a or -3b,
respectively, and may act synergistically, or Akt phosphorylation
at both sites is required for full activity (Vanhaesebroeck and
Alessi, 2000). Also, GSK-3b regulates mTOR and Akt473 phos-
phorylation through phosphorylation of Rictor at Ser1235 in the
mTORC2 complex (Chen et al., 2011). It is over expressed under
insulin stimulation and at least 10 Ser residues can be phos-
phorylated by multiple kinases including protein kinase A and
protein kinase C (Eldar-Finkelman et al., 1996). Thus a differential
phosphorylation and dephosphorylation of upstream Akt and
subsequently of GSK-3 isoforms in a cellular context seems to
be critical for the development of IR. Additionally, GSK-3b also is
capable of inducing Ser phosphorylation of IRS-1 which might be
disruptive for insulin signaling (Eldar-Finkelman et al., 1996).
Moreover, the presence of two isoforms of GSK-3, their distinct
but overlapping roles in cellular function, and their differential
phosphorylation or shuttling between nucleus and cytoplasm
makes their functional characterization an important subject of
investigation concerning the development of a GSK-3-based
therapeutic strategy.
A systematic investigation of the molecular basis of HCV-
induced IR (HCV-IR) in chronic infection was not possible pre-
viously because there were no small animal models or cell culture
systems available until recently. None of these models, however,
have been utilized to characterize HCV-IR. The ability of insulin to
lower the plasma glucose level was impaired in a transgenic HCV
core protein mouse model similar to what has been observed in
chronic hepatitis C patients (Shintani et al., 2004). Accordingly,
the core protein has been found to up-regulate phosphorylation of
IRS-1 at Ser312 and to regulate IRS-1 in a genotype-speciﬁc
mechanism (Banerjee et al., 2008; Pazienza et al., 2007). Another
viral protein, NS-5A can bind to PI-3K and activate Akt (Street
et al., 2004). While these viral proteins potentially can lead to IR
by impairing the downstream Akt/PKB signaling pathway, it is
still of limited applicability to understand the overall mechanism
of HCV-IR in the absence of testing for other viral proteins. In this
respect, studies on the signaling pathways utilizing clinical speci-
mens are limited. In HCV-infected liver specimens from nonobese
and nondiabetic patients given insulin, a decrease in IRS-1 Tyr
phosphorylation was accompanied by signiﬁcant reductions in
IRS-1/PI-3K activity suggesting a direct interaction between HCV
and the insulin-signaling pathway (Aytug et al., 2003). Therefore,
identifying and dissecting the pathways involved in IR by using a
cell culture system could be of great beneﬁt.
Both HCV and dengue virus of the Flaviviridae family and several
other viruses induce an autophagic response in infected cells as a
possible mechanism to facilitate viral infection, replication or patho-
genesis (Ait-Goughoulte et al., 2008; Lee et al., 2008; Sir et al., 2008).
But its connection with IR is not known, although the emerging role
of autophagy in the pathophysiology of diabetes mellitus has been
recognized recently (Jung et al., 2008; Meijer and Codogno, 2007;Miquilena-Colina et al., 2011). Generally, mTOR, a Ser/Thr kinase,
integrates signals from nutrients and growth factors to regulate cell
growth as well as organ and body size in a variety of organisms
(Alessi et al., 2009). When inhibited, mTOR leads to the induction of
autophagy in which cytosolic proteins and organelles are seques-
tered by double-membraned vesicles known as autophagosomes. Its
outer membrane fuses with lysozomes allowing access to the inner
content of the vesicles for subsequent degradation (Codogno et al.,
2012). Formation of this vesicle involves several steps including
nucleation, expansion and completion or closure. The initial seques-
tering component is the membrane-derived phagophore from which
the autophagosome originates. Most autophagy-related proteins
(Atg) are co-localized at the phagophore assembly site (PAS) to
participate in vesicle formation in a concerted manner (Codogno
et al., 2012; Geng and Klionsky, 2008). For instance, Beclin-1, an
ortholog of yeast Atg6, interacts with the class III PI-3K kinase
complex in the nucleation step and also serves as a Bcl-2/Bcl-XL
binding protein to regulate autophagy negatively (Sinha et al., 2008).
Two conjugation systems of Atg proteins are involved in the
expansion and closure of the autpophagosome formation; these are
essential in autophagy as mutations of any member of the con-
gjugates or of the components required for their formation results in
a defect in autophagosome formation (He and Klionsky, 2009; Xie
and Klionsky, 2007). First, Atg12, being activated by an E1-like
enzyme, Atg7, is conjugated to Atg5 and formation of this Atg12–
Atg5 conjugate is functionally necessary for the end product of the
second conjugation system, microtubule-associated protein1 light
chain 3 (LC3,Atg8) conjugated to phosphatidylethanolamine (PE).
The Atg12–Atg5 conjugates not only facilitate the lipidation of LC3
(LC3-II or LC3-PE), but also direct its correct localization in the
autophagosomal membrane (Codogno et al., 2012; Geng and
Klionsky, 2008). Interestingly, Atg12–Atg5 conjugation occurs con-
stitutively and virtually there is no free Atg5 present in cells (Lee
et al., 2008; Mizushima et al., 2001); this conjugation is irreversible,
whereas lipidation of LC3 is reversible and cell line dependent
(Mizushima et al., 1998; Mizushima et al., 2001). Therefore, the
protein levels and redistribution of Atg12–Atg5 and/or LC3-II con-
jugates are considered as hallmarks of autophagy and used to
measure autophagic activity (Kabeya et al., 2000). Several studies
report their up regulation during this process (Kim et al., 2006; Park
et al., 2012; Wang et al., 2012; Yang et al., 2010b; Zou et al., 2012).
Currently, the study of autophagic response under different
physiological or pathological conditions is under intense investi-
gation. An inducer of autophagy, rapamycin, also elicits Ser
phosphorylation of IRS-1 at Ser312 through the Rapto-mTOR-
S6K1-dependent pathway (Huynh et al., 2007; Shah and Hunter,
2006). Although suggestive, a possible role for autophagy in HCV
infected cells during IR development has not been systematically
investigated in a cellular model by key biochemical criteria
(Blumer et al., 2008; Meijer and Codogno, 2007; Sarbassov
et al., 2005b). Toward this goal, we report the characterization
of a cell-based model that mimics chronically infected HCV and
exhibits IR as judged by critical parameters controlling both
glucose homeostasis and insulin signaling pathways. Our results
suggest that in addition to the disruption of glucose homeostasis
and dysregulation of insulin signaling, autophagy in infected cells
might have a contributory role in HCV-IR.Results
HCV infected liver cells in culture mimicking chronic infection have a
reduced growth rate
We used a hepatoma cell line (Huh 7) stably transfected with an
HCV genome (genotype 2a) that produces and secretes continuously
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independent cell stocks after continuous culture over varying
periods of time (12, 19 and 23 weeks). These cells show evidence
of IR by a disruption of glucose homeostasis and the insulin-
signaling pathway, as described below. The doubling time of this
cell line (designated as Huh.HCV2a) was about 1.5-fold longer than
the control cells (not shown). For a qualitative comparison of
infected and uninfected cells and to determine whether the reduced
growth rate was due to a reduced rate of proliferation, we measured
new DNA synthesis by the incorporation of EdU, a nucleoside
homologue, by immunoﬂuorescence microscopy as described under
the Materials and methods section (Salic and Mitchison, 2008). Our
results show that HCV infected cells were larger in size than the
uninfected control Huh 7 cells (Banerjee et al., 2008) and exhibit
lower ﬂuorescent intensity under the same experimental conditions
and magniﬁcation indicating a lower rate of DNA replication
(Fig. 1A). The HCV infected cell line used in this study exhibited a
reduced growth rate and cellular proliferation compared to the
parental uninfected cells.
To investigate the ability of the HCV infected cells to con-
tinuously produce virus, as in chronic infection, we harvested the
cell culture media after passing the cells every 3–4 day for 12
weeks. The virus particles were concentrated and fractionated
through an iodixanol gradient, and the viral concentration deter-
mined for each fraction. The results show that the majority of
the HCV RNA was concentrated in fractions 11 and 12 corre-
sponding to a density of 1.14–1.15 g/mL (Fig. 1B). This is in goodHuh 7
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Fig. 1. (A) Proliferation studies. Cells were permeabilized and labeled with a nucleosi
Materials and methods section and green ﬂuorescence was examined under a ﬂuoresce
12 weeks of continuous passage, cell culture media was concentrated and loaded onto a
of the gradient. The density of each fraction is in g/mL and the HCV RNA copy numbeagreement with those reported for HCV puriﬁed from infected cells
in another laboratory and these particles were infectious
(Lindenbach et al., 2005; Wakita et al., 2005). Taken together, the
cell line Huh.HCV2a mimics persistently infected cells with reduced
ability to proliferate and to secrete virus in the media for at least
three months.
Disturbance of glucose homeostasis in HCV infected cells
As a test of IR, we examined how HCV infection inﬂuences glucose
uptake from the media under insulin stimulation. Semiconﬂuent cells
in serum-free media were stimulated with 100 nM of insulin for 2 h,
the ﬁnal 30min being in the presence of 3H-2-deoxy-glucose. Our
results show that glucose uptake under insulin stimulation was about
2- to 3-fold less in cells infected with HCV when compared to
uninfected cells (Fig. 2A).
To determine the effect on glucose metabolism, we next
focused on two cellular proteins that play a key role in this
process; one is a kinase, GSK-3, which is present in two isoforms,
a and b, and was initially identiﬁed as a regulator of glycogen
synthesis in response to insulin. They negatively regulate various
pathways involved in cell growth and proliferation and are
inactivated by Ser21 and Ser9 phosphorylation, respectively, to
turn on genes involved in various pathways (Eldar-Finkelman
et al., 1996; Sutherland et al., 1993; Welsh et al., 1996). The other
cellular protein is an enzyme, GS, a substrate for GSK-3 that could
be inactivated by Ser641 phosphorylation (Pearce et al., 2004).Huh.HCV2a
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Fig. 2. Disturbance in glucose homeostasis. (A) Glucose uptake. The ability of the
HCV infected (Huh.HCV) and uninfected (Huh) cells to take up glucose was
measured using 3H-2-deoxy-glucose under conditions of insulin stimulation
(Ins; 100 nM, 2 h) compared with no insulin stimulation, (Po0.05).
(B) Detection of GSK-3 by Western blot analysis. Two different amounts of cellular
proteins (50 mg and 75 mg) in lysates from HCV infected and uninfected cells were
fractionated and subjected to Western blot analysis as described in the text. Actin
was used as a loading control when appropriate. GSK-3a, GSK-3b and the
phosphorylated species were detected with speciﬁc antibody as indicated in the
Materials and methods section. A normalized average ratio of GSK-3a to GSK-3b
(a/b) is shown at the bottom of the ﬁgure under each lane. Lysates from
interferon-cured cells (cured) and Akt-induced Jurkat cells (Pos) were run in the
same gel as controls. (C) Detection of glycogen synthase (GS) by Western blot
analysis. Two different amounts (50 mg and 75 mg) of total proteins were run in
parallel from uninfected, infected and interferon-cured cells and probed with
speciﬁc antibodies. Total GS and GS Ser641 (pGS) are marked. Actin, loading
control.
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cells treated with calyculin A to induce Akt as the positive control.
Our results show that the GSK-3a level is about 30% more than
the GSK-3b level in HCV infected cells, whereas GSK-3bwas about
30% reduced in Huh.HCV cells, resulting in an elevation of the
GSK-3a/GSK-3b ratio by about 60–90% in different experiments
(Fig. 2B). Curing infected cells by IFNa resulted in a partial shift of
this ratio to about 30–40% when compared in uninfected cells.
When probed with an antibody that recognizes GSK-3a Ser21, we
could not detect bands in any of the lanes except in the positive
control. In a subsequent analysis with GSK-3b Ser9 speciﬁcantibody, we detected high levels of phosphorylated species in
infected cells but at a very low level, if any, in uninfected cells
suggesting that Ser9 residues are differentially phosphorylated in
these cells. These results, therefore, suggest that in infected cells
GSK-3a Ser21 is not phosphorylated, but it is the GSK-3b that is
phosphorylated at Ser9. Interestingly, in the cells cured of HCV by
IFNa, GSK-3b Ser9 phosphorylation is not observed, similar to
what is seen in the uninfected Huh 7 cells providing additional
support for our observation and viral speciﬁcity. Thus, GSK-3
isoforms are differentially regulated in HCV infected cells in
which GSK-3b is inactivated by phosphorylation while GSK-3a
remains active.
GS is regulated downstream from GSK-3 by multiple-site
phosphorylation and plays a critical role in the disturbance of
glucose homeostasis (Roach, 2002; Skurat and Roach, 1995). We
measured the total GS level and its inactivating phosphorylation in
HCV infected cells by Western blot analysis (Fig. 2C). The level of
total GS is elevated by about 2-fold in infected cells compared to the
uninfected control. We observed a low level of GS Ser641 phosphor-
ylation in Huh cells which is increased by about 6-fold in the
infected cells, thus reducing its ability drastically to incorporate
glucose into glycogen. Curing of the HCV infection by IFNa inhibits
phosphorylation, thus implying viral speciﬁcity. Since GSK-3b is not
active in infected cells, it is probably GSK-3a that is involved in the
inactivation of GS downstream. It also is possible that inactivation of
GSK-3b releases inhibition of a pathway leading to the phosphor-
ylation of GS (Cohen and Frame, 2001). Taken together, our results
strongly suggest that the disturbance in glucose homeostasis seen in
persistent HCV infection is generated both by a defect in glucose
uptake and metabolism that are biochemical hallmarks for the
development of IR.
Disruption in insulin signaling pathway
Since IRS-1 and IRS-2 play important roles in postreceptor
insulin signaling, we investigated whether and how the IRS-
mediated signaling pathway is involved in defective glucose
homeostasis in HCV infected cells. To accomplish this, the
expression of IRS-1 and IRS-2 and their phosphorylation status
were examined in the infected cells. A representative Western
blot for IRS-1 and its phosphorylated product, IRS-1 Ser312 is
shown in Fig. 3A. We used two different time points (48 h and
72 h) to identify the effect of viral growth on phosphorylation, if
any, in chronic infection. The ﬁgure shows that the IRS-1 level is
increased 2–3 fold in HCV infected cells compared to the control
Huh 7 cells (left). IRS-1 is predominantly phosphorylated at
Ser312 with respect to uninfected cells which have a relatively
low level of that product (right). This site is localized to the PTB
domain that also contains phosphorphylated Tyr residues
required for the interaction of IRc or downstream docking of
proteins for positive regulation. Thus IRS-1 Ser312 phosphoryla-
tion can lead to the inhibition of IRS-1 binding to the IRc or the PI-
3K docking protein. The ratio of hyperphosphorylated IRS-1
Ser312 to IRS-1 protein in HCV infected cells varied between 75
and 200% compared to uninfected control cells in different
experiments. Other Ser residues within and outside the PTB
domain, such as at positions 302, 612 and 789, were not
phosphorylated and thus serve as a negative control (data not
shown). To further validate our observation, we determined the
status of IRS-1 Ser312 phosphorylation in three independent
Huh.HCV2a cell lines at three different time intervals spanning
12–23 weeks of infection. When normalized with respect to the
uninfected Huh internal control, we observed a 3–6 fold increase
in IRS-1 Ser312 phosphorylation in the HCV infected cells
(Fig. 3B). The level of IRc in the whole cell lysate remained
virtually unaltered in both HCV infected and control Huh 7 cells
Fig. 4. Dysregulation of PI-3K/Akt pathway. Detection and quantiﬁcation of total
Akt (Akt-T), Akt Thr308 and Akt Ser473 by Western blot analysis. Two different
amounts (50 mg and 75 mg) of lysate prepared were loaded. Actin, loading control.
Fig. 3. Disruption in insulin signaling. (A) Representative Western blot for detection and quantiﬁcation of IRS-1 and of phosphorylated IRS-1 Ser312. Biological duplicates
were used for HCV infected cells at 48 h and 72 h; 75 mg of total proteins was loaded. Tubulin, loading control. (B) Detection and comparison of IRS-1 Ser312 in three
independent Huh. HCV cell stocks prepared at different time points (12, 19 and 23 weeks). Fold changes with respect to the internal control is indicated beneath each lane.
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phosphorylation of IRS-1 Ser312 in HCV infected cells is not a
clonal artifact. Increased expression of IRS-1 may have a protec-
tive effect facilitating viral growth as observed in many cancer
cells, and IRS-1 Ser312 phosphorylation may be involved in
negative regulation of postreceptor insulin signaling leading to
IR in persistently infected cells.
To identify the defect in downstream signaling resulting from
IRS-1 Ser312 phosphorylation, we focused on the status of Akt, a
kinase that is regulated by PI-3K in many cell signaling pathways
and is activated by phosphorylation at Thr308 and Ser473
residues by PDK1 and the mTORC2 complex, respectively (Alessi
et al., 1997; Jacinto et al., 2006). A representative Western blot
with a positive control from Akt-induced Jurkat cell lysate is
shown in Fig. 4. In HCV infected cells, the total Akt level (Akt-T)
when normalized with respect to the internal control is about 50%
less than that seen in the uninfected cells, whereas phosphoryla-
tion of Akt Thr308 is increased to about 50–300% in different
experiments (Fig. 4). In contrast, phosphorylation of Akt Ser473 is
barely detectable in uninfected cells, but its level is increased by200–300% in infected cells to make the band visible. We interpret
these results to mean that IRS-1 Ser312 phosphorylation leads to
the modulation of Akt expression and to the differential phos-
phorylation of Akt Thr308 and Akt Ser473 in infected cells
through the PI-3K-Akt pathway dysregulating normal insulin
signaling. It also supports our contention that there is a dis-
turbance of glucose homeostasis in chronic HCV infection.
Induction of autophagy in chronic HCV infection
Since insulin signaling regulates autophagy negatively, and HCV
infection induces an autophagic response, we examined whether
autophagy may serve as a contributory factor in IR development. We
explored three hallmarks of autophagy, i.e., Beclin 1 expression, LC3
lipidation and Atg12–Atg5 conjugation by biochemical analysis and
immunoﬂuorescence microscopy. It is well known that during
formation of autophagosomes, LC3 is converted from a more diffuse
state to an aggregated state and is localized to the autophagic
vacuoles. When fused to green ﬂuorescent protein (GFP-LC3) and
over expressed in cells undergoing autophagy, these protein aggre-
gates are visible as puncta (green dots) under the immunoﬂuores-
cence microscope (Fig. 5A–D). We transfected the HCV infected and
the uninfected cells with the LC3 recombinant plasmid or the empty
vector. We observed clear GFP-LC3 expression in both infected
(Huh.HCV) and uninfected Huh 7 cells, but LC3-II puncta was
predominantly formed only in the former (Fig. 5B). In control Huh
7, cells with puncta were very rare (Fig. 5D). When tranfected with
empty vector, neither of the infected nor uninfected cells showed
any puncta (Fig. 5A and C). These analyses support the presence of
autophagy in infected cells.
For further analysis, we examined the status of two other
hallmarks of autophagy involved in the nucleation and expansion
stage of autophagosome formation (Geng and Klionsky, 2008;
Mizushima et al., 1998). This process could be associated with an
increased level or modiﬁcation of Beclin-1 or of Atg12–Atg5
conjugate thus regulating the level of autophagy (Geng and
Klionsky, 2008; Liu et al., 2008; Park et al., 2012; Zhao et al.,
2010). Our Western blot analyses show that Beclin1 is over
expressed in HCV infected cells in different experiments by about
50–150% at 48 h and 72 h post-culture (Fig. 6A). The conjugation
Fig. 5. (A)–(D) Induction of autophagy. Formation of LC3 puncta (green dots) when HCV infected cells were transfected with a an empty vector (A) and a plasmid (GFP-LC3)
containing LC3 fused to GFP protein (B); Huh 7 cells transfected with empty vector (C) and GFP-LC3 (D). The bar represents 25 um. Nuclei were stained blue with 4’,6-
diamidino-2-phenyl indole dihydrochloride (DAPI). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
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in the autophagic pathway as it regulates the last stage of LC3-PE
(LC3-II) conjugation followed by their recruitment to the autop-
hagosomal membrane. We identiﬁed a band of about 53 kDa with
Atg5 antibody which corresponds to the molecular weight of the
Atg12–Atg5 conjugate, and the intensity of this band increased
from 50% to 200% with increasing time (24 h to 72 h) in culture
(Fig. 6B). The Atg12 antibody recognized this complex relatively
poorly, but a comparable increase in the level of the conjugate
was observed (Fig. 6C). When the whole blot was probed, no free
Atg5 (33 kda) or Atg12 (16 kda) was detected, as shown in Fig. 6D
(Supplemental data). In an over loaded (200 mg) and overexposed
blot of the whole gel probed with Atg5 antibody, we could not
detect individual Atg5 (Fig. 6E, Supplemental data). These results
suggest the participation of Atg5 and Atg12 as a conjugate in
autophagy during IR development. Taken together, the formation
of LC3 puncta together with the Western blot analyses of marker
proteins involved in the autophagic pathway strongly support theconcept that autophagy is active in infected cells with a disturbed
glucose homeostasis and dysregulated insulin signaling.Possible role of autophagy in HCV-induced IR
To investigate whether induction of IR has a direct relationship
with the genesis of autophagy, we inhibited autophagy in HCV
infected cells by 3-methyl adenine (3-MA), a known inhibitor.
Bands corresponding to Beclin1 are present in HCV infected cells
(lanes 1 and 2) that are not treated with 3-MA (Fig. 7A). Upon
treatment, Beclin 1 level was reduced by 2–3 fold. Interestingly,
repression of Beclin1 was associated with a dephosphorylation of
IRS-1 Ser312 and GS Ser641. These data, taken together, suggest
the possibility of a role for autophagy in the development of IR.
However, it is also possible that a decrease in the viral load by
3-MA is responsible, at least partially, for reduced level of IRS-1
Ser312 or GS Ser641 phosphorylation, as shown below.
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Fig. 6. Expression of autophagic markers. Detection and quantiﬁcation of autophagic marker proteins in HCV infected cells by Western blot analysis. Equal amounts of
total protein (50 mg) in whole cell lysate at each time point was fractionated and analyzed, as described in the Materials and methods section. Fold change with respect to
the internal control is indicated beneath each lane. (A) Beclin 1 (62 kda) at two different time points (B) Conjugate of Atg5/Atg12 (53 kda) (using Atg5 antibody) at different
time points of post culturing; (C) conjugated complex of Atg5/Atg12 at 48 h recognized individually by Atg5 and Atg12 antibody at two different protein concentrations.
Blots of the whole gels are shown in the Supplemental data (Figs. 6D and E).
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Fig. 7. Inhibition of autophagy by 3-MA. (A) Down-regulation of Beclin 1 along
with reversal of IRS-1 Ser312 and GS Ser641 phosphorylation. Two different
amounts of lysate were probed. Actin, loading control. (B) Semi-conﬂuent cells
were treated with increasing concentrations of 3-MA for 2 h and allowed to grow.
Viral load in the media was determined 24 h later as shown by a histogram.
Fig. 8. Coimmunopreciptation of IRS-1 Ser312 and Beclin 1. Two different
amounts of each lysate (100, 150 mg) from infected and uninfected cells were
immunoprecipitated either with IRS-1 Ser312 antibody (A) or with Beclin 1 anti-
body (B), fractionated on a 10% PAGE and probed with IRS-1 Ser312 and Beclin
1 antibody separately. Respective cell lysates were run in parallel (input) for direct
Western blot to identify bands. Speciﬁc bands for IRS-1 Ser312 and Beclin 1 and
that for IgG heavy chain are marked.
G.C. Das, F.B. Hollinger / Virology 434 (2012) 5–17 11If autophagy is associated with IR, it raises a question as to its role
in viral replication. To analyze this, autophagy was inhibited in HCV
infected cells by treating the cultures with 3-MA and then allowingthe cells to grow and secrete virus for another 72 h. Our results show
that even at 2.5 mM, the viral load in the media was reduced by
about 60% (Fig. 7B). A further increase in the 3-MA concentration
decreased the viral load progressively resulting in an 80% reduction at
7.5 mM. We also determined the number of live cells. The percentage
of viable cells, as measured by trypan blue staining, were comparable
(88–90%) in the treated and untreated control cells at each concen-
tration of 3-MA (not shown). By electron microscopy, we observed
autophagosome formation characterized by double-membraned
structures that were frequently distributed in the cytoplasm of
the infected cells but not in the control cells (results not shown).
G.C. Das, F.B. Hollinger / Virology 434 (2012) 5–1712These structures are known to facilitate virus replication and thus
supports our observation of a reduced virus load when autophagy is
inhibited by 3MA.
To identify whether there might be an interaction between IRS-1
Ser312 and autophagic proteins, we immunoprecipitated lysates
with an antibody speciﬁc for IRS-1 Ser312. The immunoblot was
probed with both IRS-1 Ser312 and Beclin 1 antibody (Fig. 8A).
We observed that both IRS-1 Ser312 and Beclin 1 bands were clearly
present in lysates prepared from HCV infected and uninfected cells
when compared with input control and control IgG lane. A similar
pattern was obtained when the same lysate was immunoprecipi-
tated with Beclin 1 antibody and probed with IRS-1 Ser312 and
Beclin 1 speciﬁc antibodies (Fig. 8B). IgG lane shows a non-speciﬁc
band of low intensity migrating faster than IRS-1 Ser312 band. Since
IRS-1 Ser312 phosphorylation and Beclin 1 are present in uninfected
cells, corresponding bands are also present in Huh lanes. Thus, both
IRS-1 Ser312 and Beclin 1 are present in the same immunocomplex,
strongly suggesting that they interact.Discussion
It is widely accepted that chronic HCV infection induces IR and
that IR not only accelerates the progression of liver disease but also
makes treatment of chronically infected patients with IFN-based
therapy more difﬁcult. The molecular basis of IR development and
the basis for non-response to conventional therapy have generated
much current interest from a therapeutic perspective. In a cell
culture system that mimics persistent infection, we have demon-
strated a disturbance in glucose homeostasis through reduced
glucose uptake, by a differential activation of GSK-3 isoforms, and
by subsequent inactivation of GS by phosphorylation downstream.
This is further accompanied by a disruption in insulin signaling
through a dysregulated IRS-1/PI-3K/Akt pathway, the biochemical
hallmark for IR. Curing infected cells with interferon treatment
reverses, at least partially, critical parameters of IR implying viral
speciﬁcity of these effects. Furthermore, our results suggest that
virus-induced autophagy might be a contributory factor in the
development of IR.
Although uptake of glucose in our study was reduced only
about 2-fold in Huh 7 cells infected with HCV genotype 2a, this
effect may be ampliﬁed in one of the ﬁve other genotypes that
may be capable of inducing IR more strongly (Duseja et al., 2009).
One of the most critical factors in glucose metabolism could be
the rate-limiting GS pathway which is the last step in glycogen
synthesis. Four different NH2-terminal sites of GS are the targets
for GSK-3-mediated phosphorylation. Phosphorylation of at least
one of these sites, GS Ser641, reduces GS activity to inhibit
glycogen synthesis (Skurat and Roach, 1995). The two GSK-3
isoforms, a and b, are constitutively active and usually regulate
pathways negatively. They display both overlapping and distinct
roles in different tissues with GSK-3amore active in the liver, and
their speciﬁcity for GS Ser641 phosphorylation is not currently
understood (Matsuda et al., 2008; Patel et al., 2008). We have
observed that GSK-3a remains active in both infected and unin-
fected cells, whereas GSK-3b is predominantly inactivated in
infected cells through Ser9 phosphorylation. As other kinases
and phosphatases can participate in the phosphorylation of GS,
the level of GS Ser641 phosphorylation may not strictly correlate
with Ser9 or Ser21 phosphorylation (Roach, 2002). Expression and
inactivation of GSK 3 isoforms also may be regulated by the
proliferation status of the infected and uninfected cells. However,
it has been proposed that Wnt protein of the Wnt-b catenine
pathway can inactivate GSK-3 isoforms at the same site as Akt,
and this may lead to dephosphorylation of GS through a distinct
mechanism (Ding et al., 2000; Yuan et al., 1999). It remains to beunderstood whether and how differential activation of GSK-3
isoforms participate either directly or indirectly in GS phosphor-
ylation or glucose homeostasis (Mora et al., 2005); it could be
speculated that if GSK-3a is involved, a second factor might be
needed to phosphorylate GS in HCV infected cells that could be
supplied by GSK-3b Ser9-mediated gene activation. In HCV
infected cells cured by IFNa, dephosphorylation of GSK-3b Ser9
occurred similar to what was seen in the Huh 7 control cells
implying viral speciﬁcity of Ser9 phosphorylation (Fig. 2B). This
phosphorylation may be induced by either or both of Akt Thr308
and Akt Ser473, where phosphorylation at both sites simulta-
neously may be required for full activity (Cross et al., 1995). The
total Akt level under our assay conditions is reduced by about
2-fold in infected cells, while both Akt Thr308 and Akt Ser473 are
increased by about 50–300% in different experiments. Since Akt is
phosphorylated by two different kinases, the differential Akt
phosphorylation of GSK-3 seems to be a complex one and will
require further study. Interestingly, recent studies suggest that
GSK-3b can serve upstream from Akt as well, reducing the
mTORC2-mediated Akt Ser473 phosphorylation through phos-
phorylation and dissociation of Rictor from the mTOR. Rictor
complex (Alessi et al., 1997; Chen et al., 2011; Sarbassov et al.,
2005b) and inactivation of GSK-3b may therefore increase Akt
Ser473 phosphorylation. On the other hand, mTORC1 activated
S6K1 phosphorylates Rictor at Thr1135 to stimulate mTORC2-
mediated Akt phosphorylation at Ser473, implicating a cross-talk
between GSK-3b, mTOR and Akt (Julien et al., 2010). This suggests
the presence of a complex feed-back with regulatory loops, one
involving Akt and GSK-3 and the other involving mTOR and Akt or
mTOR and GSK-3. In the type II diabetic rat, a reduced Akt Ser473
phosphorylation (30%) has been observed when compared to the
nondiabetic rat even after insulin administration, but the status of
Akt Thr308 was not examined in the same experiment which
seems to be an equally important prognostic factor in human
pathogenesis (Rondinone et al., 1999). An up-regulation of Akt
Ser473 by HCV core protein or by transfected HCV RNA in Huh
7 cells, as observed by other investigators, supports our observa-
tion (Banerjee et al., 2008).
We observed both an in increase in IRS-1 level as well as an
increased phosphorylation at Ser312 by about 2–4 fold in HCV
infected cells. In hepatocellular carcinoma cells, IRS-1 over
expression is frequently observed that prevents apoptosis
through the TGFb1 pathway (Furusaka et al., 1994; Nehrbass
et al., 1998; Tanaka and Wands, 1996). We observed IRS-1 Ser312
phosphorylation in three independent cell preparations harvested
after continuous culturing for 12, 19 and 23 weeks (Fig. 3B),
strengthening our conclusion that IRS-1 Ser312 may indeed serve
as a critical disruption point for postreceptor insulin signaling. It
is not known how early this impairment may occur. In one study,
IRS-1 Ser312 phosphorylation occurred in Huh 7 cells when
transfected either with genotype 2 HCV RNA or with an expres-
sion vector for HCV core protein suggesting that it might be an
early event (Banerjee et al., 2008). Among other Ser sites located
juxtaposed to the PTB domain, Ser302, Ser612 and Ser789 were
not phosphorylated, suggesting that Ser312 phosphorylation of
IRS-1 may be at the center of dysregulation of insulin signaling.
Both a protective effect of increased IRS-1 expression against cell
death and a disruption of insulin signaling by increased Ser312
phosphorylation are possibly important in HCV induced IR. Our
preliminary data as well as those from other laboratories indicate
that when Huh 7 liver cells are transfected with HCV RNA or
infected with infectious virions, virus production decreases after
several passages probably due to massive cell death (Wakita et al.,
2005; Zhong et al., 2005). This limited time span may not allow
the establishment of chronic infection and IR to develop fully as
opposed to our system of a stable cell line producing and
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infection (Cai et al., 2005). Although there are limitations in both
approaches, IRS-1 Ser312 phosphorylation, reduced glucose
uptake and increased levels of Beclin 1 are shared by both
systems (Banerjee et al., 2008; Waris et al., 2007).
Autophagic response in our HCV infected cell culture system is
in agreement with those reported earlier (Ait-Goughoulte et al.,
2008; Lee et al., 2008; Mizui et al., 2009; Sir et al., 2008). Although
modiﬁcation of autophagy proteins are a common occurrence in
the process of autophagy, their over expression is also reported in
the literature. In our study, Beclin-1 levels were increased is about
50–100% in infected cells and the level of Atg12–Atg5 conjugates
varied by about 50–200% in infected cells between 24 h and 72 h
post culture. Although Atg12 antibody recognized this conjugate
relatively poorly, the level of this conjugate in the infected cells
was comparable (Fig. 6C). Increased levels of these marker
proteins may suggest the presence of increased levels of autop-
hagy or number of autophagosomes over the basal level and is, in
general, in agreement with other reports (Kim et al., 2006; Liu
et al., 2008; Mai et al., 2012; Park et al., 2012; Wang et al., 2012;
Zhao et al., 2010). It is reported that stimulation of the Atg12–
Atg5 conjugate may also be caused by ribosomal RNA, and that
the two systems being involved in protein metabolism may
communicate in this fashion (Shao et al., 2007). As shown in the
Supplemental data (Fig. 6D and E), we were unable to detect free
Atg5 even by overloading the gel. This is in agreement with
previous reports showing that there is virtually no free Atg5 in
cells and almost all Atg5 exists as an Atg12–Atg5 conjugate (Liu
et al., 2008; Mizushima et al., 2001). The Atg12 antibody, how-
ever, recognizes the epitope poorly in the conjugated form. Since
sequential conjugation of Atg proteins are involved in the expan-
sion and completion of autophagosome formation, the process of
conjugation might be more important than the level of the
individual proteins. A faint band of about 140 kda was present
in the overexposed Atg5 blot that possibly could be an inter-
mediate in the conjugation process of Atg proteins or a non-
speciﬁc band and is outside the scope of the current work
(Supplemental data, Fig. 6E).
Recently, the emerging role of autophagy in the pathophysiol-
ogy of diabetes mellitus has been recognized (Gonzalez et al.,
2011). We report here that all three processes, the disturbance of
glucose homeostasis, dysregulated insulin signaling or induction
of autophagy are contributory factors in the development of IR.
Our following observations and those recently reported from
others suggest a possible contributory role of autophagy in
HCV-IR. Inhibition of autophagy by 3-MA not only inhibits the
expression of Beclin 1 in infected cells, but it also inhibits
phosphorylation of IRS-1 Ser 312 and GS Ser641 (Fig. 7); also,
our immunoprecipitation experiment shows the presence of IRS-1
Ser312 and Beclin 1 in the same immunocomplex suggesting that
they interact and this interaction possibly plays a role in the
development of IR. It has been reported recently that both dengue
virus and HCV induce autophagy of lipids in virus infected cells to
alter lipid metabolism (Heaton and R et al., 2010; Vescovo et al.,
2012). Free fatty acid (FFA) released in this process can contribute
to IR directly (Boden, 2003; Dong and Czaja, 2011; Heaton and
Randall, 2010; Vescovo et al., 2012). Also, generation of FFA
induces beta oxidation in the mitochondria resulting in an
increased ATP production to stimulate viral replication. Since
inhibition of autophagy by 3-MA reduces virus yield, autophagy
may also facilitate viral replication utilizing double-membraned
closed structures at the early stage of autophagosome formation
that are visible under the electron microscope (our unpublished
observation). We cannot, however, rule out the possibility that
reduced viral replication by 3-MA treatment also has a contrib-
utory role in the reduced phosphorylation of IRS-1 Ser312 and GSSer641. Several other studies indirectly support a contributory
role of autophagy in IR. An autophagy inducer, rapamycin,
induces IRS-1 Ser312 phosphorylation through the mTOR/S6K1
pathway suggesting a connection between autophagy and IRS-1
phosphorylation (Shah and Hunter, 2006). Inhibition of GSK-3b
activity by chemical inhibitors in the IRS-1–GSK-3–GS pathway
also induces autophagic cell death by the Bif-1 dependent path-
way implicating GSK-3b upstream from the autophagic pathway
(Yang et al., 2010a). While preparing this manuscript, a require-
ment of Bcl-2 regulated autophagy in muscle glucose homeostasis
was also reported that support our study (He et al., 2012).
A potential pathway linking the IRS-1–GS axis with autophagy
through mTOR signaling is shown schematically in Fig. 9. In
addition to the Jak–Stat pathway, IFNa also can use the IRS-1/
Akt pathway (Lok and McMahon, 2001; Uddin et al., 1995; Uddin
et al., 1997; Uddin et al., 2000). As a result, IRS-1 Ser312
phosphorylation could become a contributory factor in the
development of a poor response to IFN-based therapy by the
disruption of normal insulin signaling. Using this cell culture
model, cross-communication of insulin signaling with IFN and the
autophagic pathway may provide valuable insight into how IR can
be minimized to control viral infection and the occurrence
of T2DM.Materials and methods
Cell lines, plasmids and reagents
The development of the hepatoma cell line, Huh 7, supporting
HCV replication has been described (Lindenbach and Rice, 2005).
The cell line Huh.HCV2a was derived from these cells and harbors
a chromosomally integrated cDNA of full length genotype 2a HCV
genomic RNA as previously described (Cai et al., 2005). The cells
(designated as Huh.HCV2a) were selected by a very low concen-
tration of blasticidin (from 5 mg/mL to 2.5 mg/mL). These cells
were maintained in Dulbecco modiﬁed Eagle medium (DMEM)
containing 10% fetal bovine serum, nonessential amino acids in
HEPES buffer (pH 7.2), and 5000 units of penicillin and strepto-
mycin per mL. The cells were split every 3–4 day and the virus
load in the media measured periodically by RT-PCR as described
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harvested cells at different time points to evaluate the status of
the proteins of interest.
The hepatoma cell line, Huh 7, was a gift from Dr. Charles Rice,
Rockefeller University, New York. For the in vivo labeling experi-
ment, Edu labeling kit was purchased from Invitrogen (Carlsbad,
CA). Iodixanol was purchased from Sigma (Saint Louis, MO).
Mouse, rabbit or goat antibodies to IRS-1, Atg5, Atg12, GS and
actin were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA; Cell Signaling, Danvers, MA); IRS-1 Ser312 from Abcam
(Cambridge, MA); and Beclin1, GSK-3a, GSK-3b, GSK-3aSer21,
GSK-3bSer9, IRS-1 Ser302, Ser612, Ser789 and GS Ser641, Atg5,
Atg12 and tubulin from cell signaling (Danvers, MA) including
conformation speciﬁc secondary antibody and anti-mouse HRP
for detecting secondary antibody in IP experiments.Cell growth and proliferation assay
For the cell proliferation assay, we used a Click-iTs EdU cell
proliferation assay kit (Invitrogen, Carlsbad, CA). This assay offers
a direct and accurate detection of new DNA synthesis that not
only measures the proliferation of individual cells, but also allows
detection of cells on any platform. The assay is based on a two-
step click reaction involving copper-catalyzed triazole formation
of an azide dye and an alkyne. Both azides and alkynes are
biologically unique, inert, stable and extremely small molecules.
The assay uses a modiﬁed nucleoside, EdU (5-ethynyl-20-deox-
yuridine), that is incorporated during DNA synthesis (Salic and
Mitchison, 2008). The EdU contains both the alkyne and the
ﬂuorescent dye used to detect the new DNA that contains the
azide. We grew cells on cover slips to 60–70% conﬂuency. Cells
were washed and exposed to EdU according to the manufacturer’s
protocol. The cells were ﬁxed, permeabilized and examined under
the immunoﬂuorescence microscope. The ﬂuorescent intensity of
the cells was compared under the same experimental condition
and the lower the intensity, the slower is the rate of proliferation.Determination of viral load in the culture media of insulin-resistant
cells
Virions secreted in the media were concentrated by centrifu-
ging at 27,000 rpm for 5 h in an SW28 rotor over a 20% iodixanol
cushion. The concentrated crude virion preparation was layered
over a 10–40% iodixanol gradient and centrifuged at 40,000 rpm
for 16 h in an SW41 rotor at 8 1C. following which 0.75 mL
fractions were collected from the bottom. The density of each
fraction and corresponding viral load were determined, and the
peak HCV RNA fraction was examined by electron microscopy for
the presence of virions.
To determine virus load, viral RNA was isolated using a kit
from Qiagen (Qiagen Science, MD). The RNA was ampliﬁed by RT-
PCR using a Light Cycler III from Roche with SYBR Green as the
ﬂuorescent probe. A 226 bp segment in the 50-noncoding region
was ampliﬁed by a forward and reverse primer for ampliﬁcation:
(forward) 50-GTCTAGCCATGGCGTTAGTATGAG-30 (np 77–100);
(reverse) 50-ACCCTATCAGGCAGTACCACAAG-30 (np 302–280).
The melting peak for the viral RNA differs by about 8–10 1C from
that of the primers. RNA was quantiﬁed from a standard curve
drawn with a known concentration of HCV.2a RNA synthesized by
a coupled in vitro transcription-translation system using a geno-
mic clone pJFH.1 (Promega, Madison, WI) and was expressed as
copies/mL.Curing of HCV infection
To cure cells from HCV infection, we treated cultured cells
with a physiological concentration of IFN alpha (100 pg/mL) for
72 h in three consecutive passages, as described (Erickson et al.,
2008). The level of viral load was measured in the supernatant,
and the absence of detectable viral RNA of the concentrated
media was taken as a measure of cure. Cell lysates were prepared
from these cells and used as a negative control in the Western
blot experiments.
Measurement of glucose uptake
For glucose uptake experiments, HCV infected Huh 7 cells and
the uninfected control cells were plated in 12-well plates. At 24 h,
cells were treated with insulin (100 nM) for 2 h, the last 30 min in
the presence of 1 mCi of 3H-2-deoxy glucose (6 Ci/mmole). At the
end of the incubation time, cells were washed with PBS and lysed
with 1N NaOH. Cell lysate was transferred to scintillation vials
and counted. The percentage incorporation of 3H glucose is
compared for the two cell lines as described in the text (Ciaraldi
et al., 1995).
Inhibition of autophagy
To inhibit autophagy, semiconﬂuent cells were exposed for 4 h
to 2.5 nM of 3-methyl-adenine (3-MA), washed and allowed to
grow for another 16–20 h. Cells were harvested and autophagic
proteins were analyzed by Western blotting as described below.
Virus load was determined by quantifying viral RNA in the media
by RT-PCR from cell cultures exposed to increasing concentrations
of 3-MA up to 10 nM.
Immunoﬂuorescence microscopy
For immunoﬂuorescence studies, Huh 7 cells were grown on
round cover slips in a 24-well plate. After 24 h, cells were
transfected with 100 ng of pEGFP-LC3 or pEGFP-C1. The dot
formation by GFP-LC3 was detected after another 24 h under a
ﬂuorescence microscope. All the cells expressing GFP were
counted and cells with Z5 dots were deﬁned as autophagy
positive cells. Therefore, the percentage of cells showing signiﬁ-
cant dot formation is equal to the number of autophagic cells
divided by total number of GFP-expressing cells (Kabeya et al.,
2000).
Western blots (WB) and immunoprecipitation
Cells were washed with ice cold, calcium-free, phosphate
buffered saline and 70–100 million cells were suspended in
1 mL of a lysis buffer containing 20 mM Tris HCl (pH 7.4),
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100,
2.5 mM sodium pyrophosphate, 1 mM b-glycerol phosphate,
1 mM sodium orthovandate, 1 mM PMSF and one-tenth volume
of an anti-protease cocktail (Sigma, Saint Louis, MO). The lysate
was passed through an 18-gauge hypodermic needle and incu-
bated on ice for 10 min. It was then centrifuged at 4 1C at
14,000 g for 30 min. The lysate was aliquoted and stored at
80 1C. For Western blot analysis, equal amounts of protein (50–
100 mg) for HCV-producing cells and uninfected control Huh
7 cells were fractionated on an SDS-polyacrylamide gel electro-
phoresis apparatus. The proteins were then transferred to a
polyvinylidene diﬂuoride membrane. The membrane was then
blocked with 5% Blotto for nonspeciﬁc proteins and reacted
overnight with mouse, rabbit or goat antibody against target
proteins. After repeated washings, the immunoreactive bands
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– mouse or – goat secondary antibody. For immunoprecipitation
experiments, about 100–125 mg of total proteins were treated
with primary antibody for 1 h at room temperature and an
additional hour in the presence of 20 mL of Protein agarose beads.
The immunoprecipitates were collected by low speed centrifuga-
tion and washed thrice with the lysis buffer by repeated resus-
pension and centrifugation, and ﬁnally solubilized in 25 mL of SDS
electrophoresis buffer. Proteins in the supernatant were size-
fractionated by SDS-PAGE and transferred to membranes for
analysis of proteins that interact with IRS-1 Ser312 (Shivakumar
and Das, 1996). The bands were visualized by an enhanced
chemiluminescence detection system, ECL plus (Amersham Bios-
ciences, Piscataway, NJ), and quantiﬁed by a phosphor imager.
The membrane was rinsed at 60 1C for 30 min with stripping
buffer (100 mM 2-mercaptoethanol, 2% SDS and 62.5 mM Tris–
HCl, pH 6.7) to treat with another antibody of interest when
required. The presence of the Beclin 1 band was also conﬁrmed by
using an IgG light chain-speciﬁc secondary antibody (Jackson
Laboratory, Bar Harbor, ME). When appropriate biological dupli-
cates were made intentionally by carrying out measurement at
two different time points of cell growth; otherwise two different
amounts of proteins for each cell lysate were analyzed as
indicated in the ﬁgure legends. In experiments to analyze Akt,
GS and GSK-3, we used as a positive control lysates from Jurkat
cells in which PI-3K/AKT pathway was stimulated by calyculin A.
Cell lysates from IFN-cured cells were used as negative control.
Both tubulin and actin were interchangeably used as a loading
control.
Statistical signiﬁcance
For cell growth (n¼4), glucose uptake (n¼3) and IRS-1
expression (n¼3) experiments, data obtained in multiple experi-
ments were statistically evaluated by the Student t-test. Po0.05
(two-tailed) was considered as statistically signiﬁcant.Acknowledgment
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